Literature DB >> 7948523

Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents.

G A Losonsky1, A Wolf, R S Schwalbe, J Nataro, C B Gibson, E W Lewis.   

Abstract

Following neurosurgery necessitated by intractable seizures, Enterococcus faecium meningitis that was resistant to ampicillin, a high-level aminoglycoside (MIC, > 2,000 micrograms/mL), and vancomycin developed in a 6-year-old boy. Treatment with intrathecal teicoplanin in combination with intravenous clindamycin, rifampin, and ampicillin was successful. The role of intravenous and intrathecal antibiotics in treatment of this infection is discussed. This case is illustrative of the safety and potential usefulness of intrathecally administered teicoplanin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948523     DOI: 10.1093/clinids/19.1.163

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 2.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

Review 3.  Treatment options for vancomycin-resistant enterococcal infections.

Authors:  Peter K Linden
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Treatment of enterococcal pyelonephritis with trovafloxacin and rifampin: in vitro-in vivo contrast.

Authors:  J Z Montgomerie; D G Schick
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 5.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  [Antibiotic diffusion to central nervous system].

Authors:  J M Cabrera-Maqueda; L Fuentes Rumí; G Valero López; A E Baidez Guerrero; E García Molina; J Díaz Pérez; E García-Vázquez
Journal:  Rev Esp Quimioter       Date:  2018-01-31       Impact factor: 1.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.